Accumulation of copper and other metal ions, and metallothionein I/II expression in the bovine brain as a function of aging

Journal of Chemical Neuroanatomy

Volumn 36, Issue 1, 2008, Pages 1-5

  Zatta, Paolo ^a   Drago, Denise ^a   Zambenedetti, Pamela ^b   Bolognin, Silvia ^a   Nogara, Elisa ^a   Peruffo, Antonella ^c   Cozzi, Bruno ^c  

^a CNR   (Italy)

^b General Hospital   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Aging; Oxidative stress

Indexed keywords

COPPER; GLIAL FIBRILLARY ACIDIC PROTEIN; MAGNESIUM; METALLOTHIONEIN I; METALLOTHIONEIN II; ZINC;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL FUNCTION; CELL LINE; CENTRAL NERVOUS SYSTEM; CEREBELLUM CORTEX; CONCENTRATION (PARAMETERS); COW; EPENDYMA CELL; IMMUNOHISTOCHEMISTRY; LATERAL BRAIN VENTRICLE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

AGING; ANIMALS; BRAIN; BRAIN CHEMISTRY; CATTLE; COPPER; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; IONS; MAGNESIUM; METALLOTHIONEIN; METALS; ZINC;

EID: 46749123426     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2008.02.008     Document Type: Article

References (36)

1. Barnham K.J., Masters C.L., and Bush A.I. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3 (2004) 205-214
2. Brown D.R. Prion protein expression aids cellular uptake and veratridine-induced release of copper. J. Neurosci. Res. 58 (1999) 717-725
3. Corrigan F.M., Reynolds G.P., and Ward N.I. Hippocampal tin, aluminum and zinc in Alzheimer's disease. BioMetals 6 (1993) 149-154
4. Cotzias G.C., Miller S.T., Papavisiliou P.S., and Tang L.C. Interactions between manganese and brain dopamine. Med. Clin. North Am. 60 (1976) 729-738
5. Deloncle R., Guillard O., Bind J., Delaval J., Fleury N., Mauco G., and Lesage G. Free radical generation of protease-resistant prion after substitution of manganese for copper in bovine brain homogenate. Neurotoxicology 27 (2006) 437-444
6. Dreosti I.E., and MacLennan A. Maternal plasma zinc levels and first trimester abortion. Early Hum. Dev. 21 (1990) 141-142
7. Frank A., Pehrson B., and Petersson L.R. Concentrations of some important elements in the liver of young cattle supplemented with selenite enriched feed. Zentralbl. Veterinarmed A 33 (1986) 422-425
8. Gooneratne S.R., Christensen D.A., Bailey J.V., and Symonds H.W. Influence of breed, and dietary Cu, Mo and S levels on biliary Cu excretion in cattle. In: Hurley L.S., Keen C.L., Lonnerdal B., and Rucker R.B. (Eds). Proceedings of the 6th Symposium on Trace Elements in man and animals (TEMA 6) (1988), Plenum Press, New York 313-314
9. Hershey C.O., Brown A., and Porter D.K. Trace element content of brain in Alzheimer's disease and aging. Trace Elem. Med. 2 (1985) 40-43
10. Hidalgo J., Aschner M., Zatta P., and Vasak M. Roles of the metallothionein family of proteins in the central nervous system. Brain Res. Bull. 55 (2001) 133-145
11. Koh T.S., and Judson G.J. Copper and selenium deficiency in cattle: an evaluation of methods of oral therapy and an observation of a copper-selenium interactions. Vet. Res. Commun. 11 (1987) 133-148
12. Lech T., and Sadlik J.K. Copper concentration in body tissues and fluids in normal subjects of southern Poland. Biol. Trace Elem. Res. 118 (2007) 10-15
13. McGeer P.L., Rogers J., and McGeer E.G. Neuroimmune mechanisms in Alzheimer's disease pathogenesis. Alzheimer Dis. Assoc. Disord. 8 (1994) 149-158
14. Miyazaki I., Asanuma M., Higashi Y., Sogawa C.A., Tanaka K., and Ogawa N. Age-related changes in expression of metallothionein-III in rat brain. Neurosci. Res. 43 (2002) 323-333
15. Mocchegiani E., Bertoni-Freddari C., Marcellini F., and Malavolta M. Brain, aging and neurodegeneration: role of zinc ion availability. Prog. Neurobiol. 75 (2005) 367-390
16. Montoliu C., Monfort P., Carrasco J., Palacios O., Capdevilla M., Hidalgo J., and Felipo V. Metallothionein-III prevents glutamate and nitric oxide neurotoxicity in primary cultures of cerebellar neurons. J. Neurochem. 75 (2000) 266-273
17. Perry G., Taddeo M.A., Petersen R.B., Castellani R.J., Harris P.L., Siedlak S.L., Cash A.D., Liu Q., Nunomura A., Atwood C.S., and Smith M.A. Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease. Biometals 16 (2003) 77-81
18. Ponzoni S., Gaziri L.C., Britto L.R., Barretto W.J., and Blum D. Clearance of manganese from the rat substantia nigra following intra-nigral microinjections. Neurosci. Lett. 328 (2002) 170-174
19. Prohaska J.R., and Bailey R.W. Regional specificity in alterations of rat brain copper and catecholamine following perinatal copper deficiency. J. Neurochem. 63 (1994) 1551-1557
20. Prohaska J.R., Downing S.W., and Lukasewicz O.A. Chronic dietary copper deficiency alters biochemical and morphological properties of mouse lymphoid tissues. J. Nutr. 113 (1983) 1583-1590
21. Rothstein J.D., Dykes-Hoberg M., Corson L.B., Becker M., Cleveland D.W., Price D.L., Culotta V.C., and Wong P.C. The copper chaperone CCS is abundant in neurons and astrocytes in human and rodent brain. J. Neurochem. 72 (1999) 422-429
22. Rowlands G.J., Manston R., Bunch K.J., and Brookes P.A. A genetic analysis of the concentrations of blood metabolites and the relationship with liveweight gain in young British Fresian bulls. Livest. Prod. Sci. 10 (1983) 1-6
23. Sassoon J., and Brown D. Copper and prion disease. In: Zatta P. (Ed). Metal Ions and Neurodegenerative Disorders (2003), World Sci., Singapore, London 279-306
24. Sensi S.L., and Jeng J.M. Rethinking the excitotoxic ionic milieu: the emerging role of Zn(2+) in ischemic neuronal injury. Curr. Mol. Med. 4 (2004) 87-111
25. Sogawa C.A., Asanuma M., Sogawa N., Miyazaki I., Nakanishi T., Furuta H., and Ogawa N. Localization, regulation, and function of metallothionein-III/growth inhibitory factor in the brain. Acta Med. Okayama 55 (2001) 1-9
26. Suttle N.F. Recent studies of the copper-molybdenum antagonism. Proc. Nutr. Soc. 33 (1974) 299-305
27. Tarohda T., Ishida Y., Kawai K., Yamamoto M., and Amano R. Regional distributions of manganese, iron, copper, and zinc in the brains of 6-hydroxydopamine-induced parkinsonian rats. Anal. Bioanal. Chem. 383 (2005) 224-234
28. Tsenkova R.N., Iordanova K., Toyoda K., and Brown D.R. Prion protein fate governed by metal binding. Biochem. Biophys. Res. Commun. 325 (2004) 1005-1012
29. Vallee B.L., and Falchuk K.H. The biochemical basis of zinc physiology. Physiol. Rev. 73 (1993) 79-118
30. Verity A. Manganese neurotoxicity: a mechanistic hypothesis. Neurotoxicology 20 (1999) 489-498
31. Wang D., and Zheng W. Alteration of saliva and serum. Concentrations of manganese, copper, zinc, cadmium and lead among career welders. Toxicol. Lett. 176 (2008) 40-47
32. Weiss J.H., Sensi S.L., and Koh J.Y. Zn(2+): a novel ionic mediator of neural injury in brain disease. Trends Pharmacol. Sci. 21 (2000) 395-401
33. +-ATPase: a possible contributing factor to neurotoxicity. J. Neurochem. 101 (2007) 313-326
34. Zatta P., and Frank A. Copper deficiency and neurological disorders in man and animals. Brain Res. Rev. 54 (2007) 19-33
35. Zatta P., Lucchini R., van Rensburg S.J., and Taylor A. The role of metals in neurodegenerative processes: aluminum, manganese, and zinc. Brain Res. Bull. 62 (2003) 15-28
36. Zatta P., Raso M., Zambenedetti P., Rocco P., Petretto A., Mauri P., and Cozzi B. Metallothionein-I-II expression in young and adult bovine pineal gland. J. Chem. Neuroanat. 31 (2006) 124-129